PSCHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with PSCH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH ETF 2 | -2.89%– | +13.44%– | +21.86%– | +30.10%– | +36.07%– | -13.90%– |
| Flows | PSCH ETF 2 | +$14M– | +$25M– | +$7M– | +$2M– | -$109M– | -$207M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH ETF 2 | +15.73%– | +19.67%– | +21.83%– | +22.87%– |
| Max drawdown | PSCH ETF 2 | -4.27%– | -15.36%– | -22.80%– | -45.76%– |
| Max drawdown duration | PSCH ETF 2 | 21d– | 168d– | 488d– | 1766d– |
Trading data
PSCH | ETF 2 | |
Last sale 9/10/2026 at 1:30 PM | $53.11 | – |
| Previous close 09/09/2026 | $53.71 | – |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
PSCH | ETF 2 | |
|---|---|---|
| Last price | $53.11 | – |
| 1D performance | -1.12% | – |
| AuM | $181.59 M | – |
| E/R | 0.29% | – |
Characteristics
PSCH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | – |
| N° of holdings | 69 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PSCH
USA
95.04%
Other
4.96%
ETF 2
Sectors
PSCH
Healthcare
100%
Other
0%
ETF 2
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.1%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
PSCH
Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.20%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%
Merit Medical Systems, Inc.
2.52%
RadNet, Inc.
2.34%
Veracyte, Inc.
2.32%
ICU Medical, Inc.
2.17%
Concentra Group Holdings Parent, Inc.
1.96%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
